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Background
Moderate amounts of caffeine can lead to an increase in
both physical and mental task performance. However, a
single dose of caffeine typically induces only 90-120
minutes of increased alertness and is often associated
with an acute “crash” state following its metabolism.
Recently, slow/sustained release caffeine (SRC) alterna-
tives have been developed to prolong the effects of caf-
feine. While prior investigations have demonstrated the
efficacy of SRC, there is currently limited information
regarding the safety of SRC during prolonged usage.
Therefore, the purpose of this study was to investigate
the effects of 28-days of daily SRC ingestion on blood
lipid profiles, comprehensive blood chemistry, and com-
plete blood counts in young, healthy men and women.
Methods
Forty healthy individuals (20 males, 20 females; age: 22.73
± 3.06 years; height: 171.68 ± 10.45 cm; mass: 74.49 ±
15.51 kg; BMI: 25.08 ± 3.66 (kg/m2) who were regular
consumers of caffeine volunteered to participate in this
randomized, double-blind, placebo controlled study.
While enrolled in the study, participants were permitted
to maintain their normal caffeine intake. Following a 12-
hour fast, participants reported to the Human Perfor-
mance Laboratory (HPL) for pre-testing. Testing con-
sisted of resting heart rate (RHR) and blood pressure
(BP) measures, followed by a resting blood draw obtained
from an antecubital vein in the superficial forearm using
a 21-gauge disposable needle stick. Upon completion of
pre-testing, participants supplemented with either
Energize™ (SUPP) or placebo (PL) for 28 days. Daily
supplementation was witnessed by lab personnel. On
weekends, participants were provided 2 dosages of SUPP
or PL to consume on each weekend day. Weekend sup-
plementation was provided in zip lock bags, which were
returned to demonstrate adherence. Post-testing occurred
24-hours after ingestion of the final dose and consisted of
the same protocol at the same time of day as pre-testing.
Within 24-hours of pre- and post-testing, blood samples
were packaged along with a requisition form for analysis
at a commercial laboratory. Statistical analysis of the data
was accomplished using a 2 by 2 repeated measures ana-
lysis of variance (ANOVA) to determine between groups
differences (SUPP vs. PL). Consent to publish the results
was obtained from all participants.
Results
Compliance was 98.3%. No significant differences
between the groups were observed for resting cardiovas-
cular measures, blood lipids, or complete blood counts. A
significant difference between groups was observed for
plasma glucose concentrations (p = 0.028); however, fol-
low-up testing revealed that pre- to post-supplementation
changes were not significant for either SUPP (p = 0.077)
or PL (p = 0.116). No other between group differences
were observed for metabolic blood chemistry. All vari-
ables remained within normal adult reference ranges.
Study participants reported no adverse events during sup-
plementation with either SUPP or PL.
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Conclusion
These findings indicate that 28 consecutive days of moder-
ate SRC ingestion in caffeine users is both safe and toler-
able. This may have important relevance in professions,
where continuous operations demand peak cognitive and
physical performance for sustained periods of time.
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